We are a global marketplace, just turned 2 this month. We endeavor to build relationships and keep adding value that will help grow your businesses. It gives me great pleasure to announce that presently MergerDomo has over 200 registered investment bankers and 60 non-financial consultants offering services for Corporates/SMEs. I am glad to present MergerDomo’s very own newsletter, specially curated for Corporates/SMEs, with a plethora of relevant Financial Information & News to keep you updated.
One of the key challenges for the SME sector during the pandemic was that of financial management & planning. The post-pandemic era should see the emergence of new opportunities and business proliferation driven by a consistent recovery of business activities. With increased investments in organic/inorganic growth, a focus on digitization, optimum financial planning and more importantly a positive outlook, businesses can be positioned to flourish in ways never seen before. I believe the worst is behind us and the best is just beginning.
COVID-19 has been a transformational moment for the pharmaceutical industry as India’s pharmaceutical exports grew 18.7% in FY21. Even though the global pharma market was shrinking by 1-2% in 2020, the industry posted its best export performance. It was spurred by the demand for the country’s generic drugs, with North America having a 34% market share.
For five years, the strategic priorities will include accelerating R&D initiatives, adapting to a rapidly evolving health care ecosystem, transforming functions using digital and information technologies, and establishing a presence in global markets.
As the world grapples with the Covid-19 pandemic, the FMCG industry records 9.4% growth in Q4. Amid unprecedented uncertainty and change across the industry, the sector is learning, innovating, and rising from disruptions transforming uncertainty into possibility and adopting a rapid change to lasting progress.
The economic stress has made consumers more discretionary in their consumption choices and has experienced value growth by increased prices of products, especially of staples. The rural market continued to perform with strong growth of 14.6% during the period, and the metro markets have registered a positive growth after two quarters.
The COVID-19 pandemic has changed a lot in the automotive sphere too. However, Budget 2021 came as a blessing for the auto industry with it making a promising comeback in FY21. Finance Minister, Nirmala Sitharaman, announced a new vehicle scrappage policy, changes in customs duties, revised taxation on petrol and diesel, and a few other related topics.
India’s commercial vehicles segment reached 80% of last year’s volumes. The passenger vehicles domestic wholesales reached nearly the same levels as last year (-2.3% Y-o-Y), while two-wheelers managed to clock 85% sales last year. Tractor sales were unaffected throughout the year, and in fact, FY21 was one of the best years for this segment. India is a prominent auto exporter and has strong export growth expectations in 2021-22, post recovering from the effects of the COVID-19 pandemic.
2020s global disruption has affected the logistics industry and gave a wealth of challenges to face in 2021. However, Indian cold chain logistics are expected to grow at 20% by 2025. These estimates are based on the sector’s performance over the past few months. This is due to a rise in online shopping, border closures, strained global freight networks, increased safety checks as they have reconstructed how the logistics industry functions.
Meeting the challenges of 2021 required a new outlook, and few conclusions seem certain in the logistics ecosystem that there need to be new operating models, a responsive supply chain, increased focus on automation, and digitalization to build a resilient and effective supply chain.
Sector
|
Deal Type
|
Description
|
Deal Size
(INR Cr) |
Link
|
---|---|---|---|---|
Pharmaceuticals
|
Buyside Acquisition
|
15-year-old State-of-the-art entity from Telangana, India is looking to acquire API manufacturers
|
150-800
|
|
Pharmaceuticals
|
Sellout
|
A Bulk Drug manufacturing entity from South India is looking to sellout.
|
60-65
|
|
Automobile
|
Product Licencing
|
Automotive 2W Electric vehicle complete solution entity from South Korea is looking for licensing Product Technology.
|
- -
|
|
Logistics
|
Sellout
|
Truck Transportation and Services entity from India is looking to sellout.
|
190-210
|
Sector | Pharmaceuticals |
---|---|
Deal Type | Buyside Acquisition |
Description | 15-year-old State-of-the-art entity from Telangana, India is looking to acquire API manufacturers |
Deal Size (INR Cr) | 150-800 |
View Deal |
Sector | Pharmaceuticals |
---|---|
Deal Type | Sellout |
Description | A Bulk Drug manufacturing entity from South India is looking to sellout. |
Deal Size (INR Cr) | 60-65 |
View Deal |
Sector | Automobile |
---|---|
Deal Type | Product Licencing |
Description | Automotive 2W Electric vehicle complete solution entity from South Korea is looking for licensing Product Technology. |
View Deal |
Sector | Logistics |
---|---|
Deal Type | Sellout |
Description | Truck Transportation and Services entity from India is looking to sellout. |
Deal Size (INR Cr) | 190-210 |
View Deal |
Taran Bedi is the Senior Associate in the Investment Banking division of MergerDomo. He helps investment bankers by finding the right counterparties for their clients.
Aditya is working as an Analyst in the investment banking division of Mergerdomo handling Deal Sourcing, Consulting, Investment bankers & PE relationships.
Disclaimer: Any information provided herein is indicative only, subject to change without notice, and does not constitute an offer to purchase or sell. The information contained in this electronic message and in any attachments to this message is confidential, legally privileged, and intended only for the person or entity to which this electronic message is addressed. If you are not the intended recipient, please notify the system manager, and you are hereby notified that any distribution, copying, review, retransmission, dissemination, or other use of this electronic transmission or the information contained in it is strictly prohibited.